It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An algorithm to describe patterns of intermittent oral corticosteroid use in the UK (n = 476,167) found that one-third of patients receiving intermittent oral corticosteroids for asthma only had short gaps (<90 days) between oral corticosteroid prescriptions sometime during follow-up. The increasing frequency pattern was more likely in patients with greater asthma severity and with more short-acting β2-agonist use at baseline. Our approach may provide a clinically relevant representation of intermittent oral corticosteroid use in asthma.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 NHS Clinical Research Facilities, Glasgow, UK
2 AstraZeneca, Gaithersburg, USA (GRID:grid.418152.b) (ISNI:0000 0004 0543 9493)
3 Observational and Pragmatic Research Institute, Midview City, Singapore (GRID:grid.500407.6)
4 Montpellier University Hospitals, Arnaud de Villeneuve Hospital, Department of Respiratory Diseases, Montpellier, France (GRID:grid.413745.0) (ISNI:0000 0001 0507 738X)
5 Royal Brompton & Harefield Hospitals, UK Severe Asthma Network and National Registry, London, UK (GRID:grid.439338.6) (ISNI:0000 0001 1114 4366)
6 King’s College London, UK Severe Asthma Network and National Registry, Guy’s and St Thomas’ NHS Trust and Division of Asthma, Allergy & Lung Biology, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
7 AstraZeneca, Cambridge, UK (GRID:grid.417815.e) (ISNI:0000 0004 5929 4381)
8 Observational and Pragmatic Research Institute, Midview City, Singapore (GRID:grid.500407.6); University of Aberdeen, Centre of Academic Primary Care, Division of Applied Health Sciences, Aberdeen, UK (GRID:grid.7107.1) (ISNI:0000 0004 1936 7291)